Company Analysis NorthWest Healthcare Properties Real Estate Investment Trust
1. Summary
Advantages
- Price (3.44 $) is less than fair price (3.84 $)
- Dividends (8.22%) are higher than the sector average (5.64%).
Disadvantages
- The stock's return over the last year (-4.9%) is lower than the sector average (4.92%).
- Current debt level 49.77% has increased over 5 years from 49.43%.
- The company's current efficiency (ROE=-14.26%) is lower than the sector average (ROE=3.95%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
NorthWest Healthcare Properties Real Estate Investment Trust | Real Estate | Index | |
---|---|---|---|
7 days | 2.9% | -4.4% | 0.9% |
90 days | 1.7% | 3.1% | 8.8% |
1 year | -4.9% | 4.9% | 12% |
NWHUF vs Sector: NorthWest Healthcare Properties Real Estate Investment Trust has significantly underperformed the "Real Estate" sector by -9.82% over the past year.
NWHUF vs Market: NorthWest Healthcare Properties Real Estate Investment Trust has significantly underperformed the market by -16.94% over the past year.
Stable price: NWHUF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: NWHUF with weekly volatility of -0.0943% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (3.44 $) is lower than the fair price (3.84 $).
Price not significantly lower than the fair price: The current price (3.44 $) is slightly lower than the fair price by 11.6%.
4.2. P/E
P/E vs Sector: The company's P/E (18.4) is lower than that of the sector as a whole (29.78).
P/E vs Market: The company's P/E (18.4) is lower than that of the market as a whole (59.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.4293) is lower than that of the sector as a whole (1.16).
P/BV vs Market: The company's P/BV (0.4293) is lower than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.4) is lower than that of the sector as a whole (4.96).
P/S vs Market: The company's P/S indicator (2.4) is lower than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-24.18) is lower than that of the sector as a whole (127.9).
EV/Ebitda vs Market: The company's EV/Ebitda (-24.18) is lower than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -34.65% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-34.65%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-30.48%).
5.4. ROE
ROE vs Sector: The company's ROE (-14.26%) is lower than that of the sector as a whole (3.95%).
ROE vs Market: The company's ROE (-14.26%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (-3.71%) is lower than that of the sector as a whole (1.77%).
ROA vs Market: The company's ROA (-3.71%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (4.91%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 8.22% is higher than the average for the sector '5.64%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 8.22% has been steadily paid over the past 7 years, DSI=0.79.
Weak dividend growth: The company's dividend yield 8.22% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (124.27%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription